Could a simple light scan replace the skin pinch test for scleroderma?
NCT ID NCT05672992
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new, non-invasive imaging technique called spatial frequency domain imaging (SFDI) to measure skin thickness in people with scleroderma, an autoimmune disease that causes skin hardening. Currently, doctors assess skin fibrosis by pinching the skin, which is subjective and varies between doctors. The study will compare SFDI with standard methods like the modified Rodnan skin score, skin biopsies, and ultrasound over 3 years in 78 participants, including healthy controls. If SFDI works well, it could become a rapid, objective tool for monitoring disease activity.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Spatial-frequency domain imaging (SFDI) - a non-invasive light-based imaging device
- What this could lead to
- If successful, SFDI could become a quick, painless way to track skin fibrosis in scleroderma, replacing imprecise pinch tests and helping doctors monitor disease progression or treatment response.
- What could go wrong
- This is an early observational study with only 78 participants, so results may not apply to all patients. SFDI might not correlate well with existing measures or prove practical in routine care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLERODERMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shapiro Outpatient Rheumatology Clinic at Boston Medical Center
Boston, Massachusetts, 02118, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New antibody drug aims to halt Scleroderma's grip
- Tiny particles may hold clues to autoimmune diseases
- Can a viagra drug heal scleroderma finger sores?
- Could a single infusion of supercharged immune cells tame incurable autoimmune diseases?
- New antibody drug firsekibart tested for scleroderma skin thickening
- Laser zaps face veins in scleroderma patients – 21 test it out